Dishman Carbogen Amcis Ltd - DISHMAN CARBOGEN Share Price

Sector: Pharmaceuticals | ISIN: INE385W01011
₹ 216.65 (-3.24%) icon21 Feb, 2024, 12:00:00 AM

Dishman Carbogen Amcis Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 2/21/2024 12:00:00 AM

    ₹ 216.65 -7.25 -3.24
  • Open
  • ₹ 222
  • Prev. Close
  • ₹ 223.9
  • Turnover(Lac.)
  • ₹ 2,133
  • Day's High
  • ₹ 225.75
  • Day's Low
  • ₹ 214
  • 52 Week's High
  • ₹ 226.3
  • 52 Week's Low
  • ₹ 103
  • Book Value
  • ₹ 259.53
  • Face Value
  • ₹ 2
  • Mkt Cap (₹ Cr.)
  • 3,396.71
  • P/E
  • 0
  • EPS
  • 0
  • Divi. Yield
  • 0

Dishman Carbogen Amcis Ltd Corporate Actions

06 Feb , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Feb , 2024

12:00 AM

01 Nov , 2023

12:00 AM

01 Nov , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

22 Aug , 2023

12:00 AM

AGM

Announcement date: 22 Aug , 2023

View Details

02 Aug , 2023

12:00 AM

02 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

15 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Mar , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

Dishman Carbogen Amcis Ltd News and Update

Image not found
  • 16 February, 2024 |
  • 11:57 PM

Recommendation: Buy; Target price: ₹581

Article Image
Image not found
  • IIFL News Service |
  • 14 February, 2024 |
  • 11:54 PM
Image not found
  • IIFL News Service |
  • 02 February, 2024 |
  • 11:37 PM

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Dishman Carbogen Amcis Ltd SHAREHOLDING SNAPSHOT
21 February , 2024 | 08:13 PM

PROMOTER - TOTAL59.32%

Indian: 59.32%

Foreign: 0%

NON-PROMOTER - TOTAL 40.68%

Institutions: 12.29%

Non-Institutions: 28.39%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Dishman Carbogen Amcis Ltd FINANCIALS

Dishman Carbogen Amcis Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Dishman Carbogen Amcis Ltd

  • Janmejay R Vyas
  • Chairman (Non-Executive)
  • Deohooti J Vyas
  • Whole-time Director
  • Arpit J Vyas
  • Managing Director & CFO
  • Sanjay S Majmudar
  • Independent Director
  • Ashok C Gandhi
  • Independent Director
  • Subir Kumar Das
  • Independent Director
  • Rajendra S Shah
  • Independent Director
  • Shrima Dave
  • Company Sec. & Compli. Officer
  • Maitri K Mehta
  • Independent Director

Summary

Dishman Carbogen Amcis Limited was incorporated in the year July 17, 2007. The Company is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries. It has manufacturing and research facilities in India, Switzerland, France, The Netherland and China. As on 31st March 2019, the total number of subsidiaries including step down subsidiaries were 14.During the financial year ended 31 March 2017, Dishman Pharmaceuticals and Chemicals Limited (DPCL) and Dishman Care Limited were merged with DPCLs subsidiary Carbogen Amcis (India) Limited, with the key objective of business consolidation and simplification of the Group structure. The name of Carbogen Amcis (India) Ltd. was changed to Dishman Carbogen Amcis Ltd. with effect from 27 March 2017.Dishman Pharmaceuticals and Chemicals Ltd was incorporated in the year 1983 as a research-oriented organization. The company set up their first manufacturing unit in Naroda for phase Transfer Catalysts. The company earned the status of Quat Company by establishing themselves in the Quat business.In the year 1995, the company formed a joint venture company with Schtz & Co, Germany called as Schutz Dishman Biotech Private Ltd. They manufacture Chlorhexidine Base, Chlorhexidine HCl, Chlorhexidine Acetate and Chlorhexidine Gluconate solution, for the European... Read More


Reports by Dishman Carbogen Amcis Ltd


Reports by Dishman Carbogen Amcis Ltd

Company FAQ

No Record Found